respiratory

Four new drugs get PBS tick

New treatments for chronic diseases including type 2 diabetes and COPD have been listed on the PBS. From June 1, new medications to be subsidised by the Pharmaceutical Benefits Scheme include: Triple-combination inhaler Trelegy for patients with moderate to severe obstructive pulmonary disease. Patients will pay a maximum $39.50 per script ($6.40 for concessional patients). ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic